Eddie Stage
Overview
Explore the profile of Eddie Stage including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feizpour A, Doecke J, Dore V, Krishnadas N, Huang K, Bourgeat P, et al.
EBioMedicine
. 2024 Oct;
109:105405.
PMID: 39437657
Background: Plasma phospho-tau 217 (pTau217) assays can accurately detect Alzheimer's disease (AD) pathology, but clinical application is limited by the need for specialised equipment. This study tests the performance of...
2.
Seibyl J, DuBois J, Racine A, Collins J, Guo Q, Wooten D, et al.
J Nucl Med
. 2022 Sep;
64(3):444-451.
PMID: 36175137
In vivo characterization of pathologic deposition of tau protein in the human brain by PET imaging is a promising tool in drug development trials of Alzheimer disease (AD). 6-(fluoro-F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine (F-MK-6240)...
3.
Stage E, Risacher S, Lane K, Gao S, Nho K, Saykin A, et al.
Alzheimers Dement (Amst)
. 2022 May;
14(1):e12308.
PMID: 35592828
Introduction: We previously reported genetic associations of the top Alzheimer's disease (AD) risk alleles with amyloid deposition and neurodegeneration. Here, we report the association of these variants with [F]flortaucipir standardized...
4.
Duran T, Woo E, Otero D, Risacher S, Stage E, Sanjay A, et al.
Brain Imaging Behav
. 2022 Jan;
16(4):1495-1503.
PMID: 35064438
Metacognitive deficits affect Alzheimer's disease (AD) patient safety and increase caregiver burden. The brain areas that support metacognition are not well understood. 112 participants from the Imaging and Genetic Biomarkers...
5.
Stage E, Svaldi D, Sokolow S, Risacher S, Marosi K, Rotter J, et al.
Alzheimers Dement (N Y)
. 2022 Jan;
7(1):e12168.
PMID: 35005201
Introduction: Analyses of off-label use of acetylcholinesterase inhibitors (AChEIs) in mild cognitive impairment (MCI) has produced mixed results. Post hoc analyses of observational cohorts, such as the Alzheimer's Disease Neuroimaging...
6.
Stage E, Duran T, Risacher S, Goukasian N, Do T, West J, et al.
Alzheimers Dement (Amst)
. 2017 Jan;
5:53-66.
PMID: 28054028
Introduction: We analyzed the effects of the top 20 Alzheimer disease (AD) risk genes on gray-matter density (GMD) and metabolism. Methods: We ran stepwise linear regression analysis using posterior cingulate...